3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell
21
Lymphoma, Mantle-Cell
13
Lymphoma, Non-Hodgkin
10
Lymphoma, Large B-Cell, Diffuse
10
Waldenstrom Macroglobulinemia
7
Lymphoma, Follicular
7
Lymphoma, B-Cell, Marginal Zone
5
Lymphoma
5
Neoplasms
4
Leukemia, B-Cell
4
Lymphoma, B-Cell
3
Burkitt Lymphoma
3
Recurrence
2
Leukemia, Prolymphocytic
2
Leukemia, Lymphoid
2
Leukemia, Hairy Cell
2
Leukemia
2
Hematologic Diseases
2
Bronchiolitis Obliterans Syndrome
2
Squamous Cell Carcinoma of Head and Neck
1
Prostatic Neoplasms, Castration-Resistant
1
Primary Central Nervous System Lymphoma (PCNSL)
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Melanoma
1
Lymphoproliferative Disorders
1
Lymphoma, AIDS-Related
1
Lymphatic Diseases
1
Leukemia, Prolymphocytic, B-Cell
1
Interventions
Specimen Handling
43
pembrolizumab
42
Biopsy
36
Magnetic Resonance Spectroscopy
34
Paclitaxel
21
Carboplatin
21
Gemcitabine
20
Nivolumab
19
Irinotecan
17
Radiosurgery
15
Cisplatin
13
Taxes
11
Pemetrexed
11
Ipilimumab
11
Fluorouracil
11
Cetuximab
11
trastuzumab deruxtecan
10
olaparib
10
Leucovorin
10
130-nm albumin-bound paclitaxel
10
abemaciclib
9
Oxaliplatin
9
Cyclophosphamide
9
Capecitabine
9
Bevacizumab
9
palbociclib
8
durvalumab
8
Fulvestrant
8
X-Rays
7
Trastuzumab
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasm Metastasis
×
ibrutinib
×
90 days
×
Clear all
No trials found.